TCF4 and prostate adenocarcinoma: RNA sequence analysis and examination of tissues obtained from men who had died from metastatic prostate cancer showed an association between increased levels of transcription factor-4 (TCF-4) and increased levels of neuroendocrine markers in the prostatic adenocarcinoma cell line resistant to enzalutamide when compared to the parental cell line.